TSE:XEF:TSX
iShares Core MSCI EAFE IMI Index ETF – TSE:XEF ETF Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 42.08 CAD | -0.32 (-0.75%) | 35.61 - 43.39 | 318.3 thousand (Above Avg) |
Market data as of 3:59PM 08/01/25. Quotes are delayed by at least 15 min.
Overview - TSE:XEF
The fund seeks to provide long-term capital growth by replicating, to the extent possible, the performance of the MSCI EAFE Investable Market Index, net of expenses. Under normal market conditions, fund will primarily invest in securities of one or more iShares ETFs and/or international equity securities. Fund’s current principal investment strategy is to employ a Sampling Strategy.
| Open | 42.14 |
|---|
| Previous Close | 42.40 |
|---|
| Day's Range | 41.77 - 42.14 |
|---|
| Avg Volume (10 Day) | 229.9K |
|---|
| Total Assets | $12.64B |
|---|
| Expense Ratio | -- |
|---|
| Yield (Trailing 12 Mo.) | 2.64% |
|---|
| Fund Inception | 04/10/2013 |
|---|
Trailing Total Returns - TSE:XEF
as of 06/30/2025
| Timeframe | TSE:XEF | S&P 500 | International Equity |
|---|
| 1 Month | 1.69% | 5.09% | 1.28% |
|---|
| 3 Month | 6.69% | 10.94% | 4.99% |
|---|
| Year-to-Date | 13.94% | 6.20% | 10.76% |
|---|
| 1 Year | 18.05% | 15.16% | 14.08% |
|---|
| 3 Year | 17.76% | 19.71% | 15.35% |
|---|
| 5 Year | 10.92% | 16.64% | 9.54% |
|---|
| 10 Year | 7.42% | 13.65% | 6.33% |
|---|
| Since Inception | 9.05% | 11.14% | -- |
|---|
Stock Sector Allocation - TSE:XEF
as of 06/30/2025
| Basic Materials | | 6.00% |
|---|
| Consumer Cyclical | | 9.50% |
|---|
| Financial Services | | 21.74% |
|---|
| Real Estate | | 3.34% |
|---|
| Consumer Defensive | | 7.50% |
|---|
| Healthcare | | 10.59% |
|---|
| Utilities | | 3.19% |
|---|
| Communication Services | | 5.64% |
|---|
| Energy | | 3.19% |
|---|
| Industrials | | 19.67% |
|---|
| Technology | | 9.65% |
|---|
Top Ten Holdings - TSE:XEF
as of 06/30/2025
| Company | YTD Return | % of Assets |
|---|
| IEFA | -- | 2.28% |
|---|
| SAP SE | -- | 1.40% |
|---|
| ASML Holding NV | -- | 1.39% |
|---|
| Nestle SA | -- | 1.15% |
|---|
| Novartis AG Registered Shares | -- | 1.02% |
|---|
| Roche Holding AG | -- | 1.01% |
|---|
| Novo Nordisk AS Class B | -- | 0.99% |
|---|
| AstraZeneca PLC | -- | 0.95% |
|---|
| HSBC Holdings PLC | -- | 0.95% |
|---|
| Shell PLC | -- | 0.93% |
|---|
Valuation & Growth - TSE:XEF
as of 06/30/2025
| Valuation | TSE:XEF | Category Range |
|---|
| Price/Earnings | 16.80 | |
|---|
| Price/Book | 1.81 | |
|---|
| Price/Sales | 1.45 | |
|---|
| Price/Cash Flow | 9.75 | |
|---|
| Dividend Yield | 3.39 | |
|---|
| LT Earnings | 8.3 | |
|---|
| Historical Earnings | 7.9 | |
|---|
| Sales Growth | 3.2 | |
|---|
| Cash-Flow Growth | 3.35 | |
|---|
| Book-Value Growth | 4.72 | |
|---|
